+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Encephalopathy Market by Treatment Type, Distribution Channel, End User, Patient Age Group - Global Forecast to 2030- Product Image
Encephalopathy Market by Treatment Type, Distribution Channel, End User, Patient Age Group - Global Forecast to 2030- Product Image
Sale

Encephalopathy Market by Treatment Type, Distribution Channel, End User, Patient Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015276
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior healthcare executives are seeking actionable intelligence in the encephalopathy market as evolving clinical needs, reimbursement models, and policy shifts redefine operational priorities. Understanding current market trends, key innovations, and regulatory challenges is vital for driving successful investment and strategic planning in this complex segment.

Market Snapshot: Encephalopathy Market Size & Growth

The encephalopathy market progressed from USD 196.85 million in 2024 to USD 209.06 million in 2025 and is projected to sustain a compound annual growth rate (CAGR) of 6.15%, ultimately reaching USD 281.70 million by 2030. This steady expansion highlights the increasing clinical emphasis on neurological disorders, primarily fueled by the growth of the aging population, surging chronic liver disease rates, and rapid advancements in diagnosis and treatment technologies.

Scope & Segmentation

This report offers a comprehensive view of current and emerging opportunities, covering all relevant segments and regional dynamics. The market is segmented as follows:

  • Treatment Types: Blood purification systems, hemodialysis devices, liver support devices, lactulose, rifaximin, liver transplantation, and shunt surgeries.
  • Distribution Channels: Hospital pharmacies, online pharmacies, and retail pharmacies.
  • End Users: Home care settings, hospitals, and specialty clinics.
  • Patient Age Groups: Adult, geriatric, and pediatric cohorts.
  • Regional Coverage: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (including United Kingdom, Germany, France, and others), and Asia-Pacific (led by China, India, Japan, Australia, South Korea, and more).
  • Technologies: Next-generation antibiotics, miniaturized extracorporeal blood purification, diagnostic imaging, biomarker platforms, minimally invasive surgical devices, and digital health integration.
  • Companies Profiled: Salix Pharmaceuticals, Abbott Laboratories, Fresenius Kabi, Sandoz International, Teva Pharmaceutical Industries, Cipla, Lupin, Apotex, Sun Pharmaceutical, B. Braun Melsungen.

Key Takeaways for Strategic Decision-Makers

  • Emerging therapies targeting the gut-brain axis are driving fundamental change in treatment development and industry competition.
  • Device innovation is improving safety, usability, and outcomes, particularly in extracorporeal support and minimally invasive surgical procedures.
  • Value-based care models are fueling strategic partnerships and incentivizing integrated care pathways, with collaborative efforts across pharmaceuticals, devices, and service providers strengthening market positions.
  • Hospital and specialty clinic consolidation enables delivery of coordinated, multidisciplinary treatment regimens and fosters adoption of advanced diagnostic and digital health solutions.
  • Regional variations in healthcare infrastructure, investment priorities, and access programs present unique opportunities for tailored commercial strategies and technology adoption.
  • Growing demand in adult and geriatric populations is emphasizing simplified, outpatient-focused protocols, while specialized solutions remain essential for pediatric and complex cases.

Tariff Impact: Navigating Policy and Supply Chain Disruption

Revised US tariff policies implemented for 2025 are significantly affecting cost structures around core technologies supporting encephalopathy care. Increased tariffs on hemodialysis and related devices have triggered expense hikes for providers, compelling budget reevaluation and procurement shifts. Pharmaceutical tariffs, specifically on active ingredients for mainstay therapies, are leading to pricing adjustments in the supply chain. Manufacturers and service providers are responding with localized manufacturing and new contracting models, working to ensure sustained access for critical therapies in a volatile regulatory climate.

Methodology & Data Sources

The research draws on extensive interviews with clinical leaders and reimbursement experts, complemented by analysis of peer-reviewed journals, industry reports, and proprietary data tracking device and pharmaceutical trends. A blend of bottom-up adoption mapping and top-down regulatory evaluation ensures robust, validated insights that reflect real-world treatment adoption and market pressures.

Why This Report Matters

  • Delivers sector-wide intelligence to inform capital allocation, operational strategy, and risk mitigation in a rapidly evolving competitive landscape.
  • Enables identification of technology and partnership opportunities, ensuring leadership can align business objectives with the changing reimbursement and therapeutic environment.

Conclusion

The encephalopathy market is advancing through clinical innovation, policy evolution, and strategic alliances. Leaders equipped with these insights can make informed decisions to optimize business resilience and improve patient care outcomes across diverse geographies.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Encephalopathy Market, by Treatment Type
8.1. Introduction
8.2. Devices
8.2.1. Blood Purification Systems
8.2.2. Hemodialysis Devices
8.2.3. Liver Support Devices
8.3. Pharmaceuticals
8.3.1. Lactulose
8.3.2. Rifaximin
8.4. Surgical Procedures
8.4.1. Liver Transplantation
8.4.2. Shunt Surgeries
9. Encephalopathy Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Encephalopathy Market, by End User
10.1. Introduction
10.2. Home Care Settings
10.3. Hospitals
10.4. Specialty Clinics
11. Encephalopathy Market, by Patient Age Group
11.1. Introduction
11.2. Adult
11.3. Geriatric
11.4. Pediatric
12. Americas Encephalopathy Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Encephalopathy Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Encephalopathy Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Salix Pharmaceuticals, Inc.
15.3.2. Abbott Laboratories
15.3.3. Fresenius Kabi AG
15.3.4. Sandoz International GmbH
15.3.5. Teva Pharmaceutical Industries Ltd.
15.3.6. Cipla Limited
15.3.7. Lupin Limited
15.3.8. Apotex Inc.
15.3.9. Sun Pharmaceutical Industries Ltd.
15.3.10. B. Braun Melsungen AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ENCEPHALOPATHY MARKET MULTI-CURRENCY
FIGURE 2. ENCEPHALOPATHY MARKET MULTI-LANGUAGE
FIGURE 3. ENCEPHALOPATHY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ENCEPHALOPATHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ENCEPHALOPATHY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ENCEPHALOPATHY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ENCEPHALOPATHY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENCEPHALOPATHY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY BLOOD PURIFICATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY HEMODIALYSIS DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY LIVER SUPPORT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY LACTULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY RIFAXIMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY SHUNT SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ENCEPHALOPATHY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ENCEPHALOPATHY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. CANADA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 49. CANADA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 50. CANADA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 51. CANADA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 52. CANADA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. CANADA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. CANADA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 55. MEXICO ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 57. MEXICO ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. MEXICO ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. MEXICO ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 91. GERMANY ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 93. GERMANY ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 94. GERMANY ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 95. GERMANY ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. GERMANY ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 98. FRANCE ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 99. FRANCE ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 100. FRANCE ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 101. FRANCE ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 102. FRANCE ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. FRANCE ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. FRANCE ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 105. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. ITALY ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 113. ITALY ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 114. ITALY ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 115. ITALY ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 116. ITALY ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. ITALY ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ITALY ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 119. SPAIN ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. SPAIN ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 121. SPAIN ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 122. SPAIN ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 123. SPAIN ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. SPAIN ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SPAIN ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 140. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. DENMARK ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 148. DENMARK ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 149. DENMARK ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 150. DENMARK ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 151. DENMARK ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. DENMARK ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. DENMARK ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 161. QATAR ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 162. QATAR ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 163. QATAR ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 164. QATAR ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 165. QATAR ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. QATAR ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. QATAR ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 168. FINLAND ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 169. FINLAND ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 170. FINLAND ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 171. FINLAND ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 172. FINLAND ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. FINLAND ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. FINLAND ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 189. EGYPT ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 190. EGYPT ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 191. EGYPT ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 192. EGYPT ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 193. EGYPT ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. EGYPT ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. EGYPT ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. TURKEY ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 197. TURKEY ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 198. TURKEY ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 199. TURKEY ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 200. TURKEY ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. TURKEY ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. TURKEY ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 203. ISRAEL ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 210. NORWAY ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 211. NORWAY ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 212. NORWAY ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 213. NORWAY ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 214. NORWAY ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. NORWAY ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. NORWAY ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 217. POLAND ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 218. POLAND ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 219. POLAND ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 220. POLAND ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 221. POLAND ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. POLAND ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. POLAND ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC ENCEPHALOPATHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 239. CHINA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 240. CHINA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 241. CHINA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 242. CHINA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 243. CHINA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. CHINA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. CHINA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 246. INDIA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 247. INDIA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 248. INDIA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 249. INDIA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 250. INDIA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. INDIA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. INDIA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 253. JAPAN ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 254. JAPAN ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 255. JAPAN ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 256. JAPAN ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 257. JAPAN ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. JAPAN ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. JAPAN ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 281. THAILAND ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 282. THAILAND ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 283. THAILAND ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 284. THAILAND ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 285. THAILAND ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. THAILAND ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. THAILAND ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN ENCEPHALOPATHY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN ENCEPHALOPATHY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN ENCEPHALOPATHY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN ENCEPHALOPATHY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN ENCEPHALOPATHY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN ENCEPHALOPATHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN ENCEPHALOPATHY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 323. ENCEPHALOPATHY MARKET SHARE, BY KEY PLAYER, 2024
TABLE 324. ENCEPHALOPATHY MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Encephalopathy market report include:
  • Salix Pharmaceuticals, Inc.
  • Abbott Laboratories
  • Fresenius Kabi AG
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Cipla Limited
  • Lupin Limited
  • Apotex Inc.
  • Sun Pharmaceutical Industries Ltd.
  • B. Braun Melsungen AG

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 209.06 Million
Forecasted Market Value ( USD ) by 2030 $ 281.7 Million
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Overt Hepatic Encephalopathy Market - Product Image

Overt Hepatic Encephalopathy Market

  • Report
  • 250 Pages
  • Global
From
Hepatic Encephalopathy (HE) Treatment - Global Strategic Business Report - Product Image

Hepatic Encephalopathy (HE) Treatment - Global Strategic Business Report

  • Report
  • 283 Pages
  • Global
From
Hepatic Encephalopathy Market Report 2025 - Product Image

Hepatic Encephalopathy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Encephalopathy- Pipeline Insight, 2025 - Product Image

Encephalopathy- Pipeline Insight, 2025

  • Clinical Trials
  • 210 Pages
  • Global
From
Developmental and Epileptic Encephalopathies (DEE) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Developmental and Epileptic Encephalopathies (DEE) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 233 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.